Events
Live Events
The HER Story Patient Ambassador program provides for you an opportunity to hear from a Genentech Oncology Nurse and connect with many others who have been affected by HER2+ breast cancer. The events last between 60 to 90 minutes and do not require a fee to attend. This program does not replace the advice of your personal healthcare team, but includes questions you may want to ask them about your diagnosis, your treatment plan, or Herceptin.
Remember that every person who has HER2+ breast cancer is unique. The experiences of the women ambassadors in this program may be different from your own. If you have any questions or concerns about your treatment, please talk to your doctor. Click below to find an event near you!
| Date & Time | Details | Venue & Address | |
|---|---|---|---|
| Mon 08/23/10 6:00 PM ET |
Topic: Nutrition |
Sheraton Four Points 800 East Park Drive Harrisburg, PA |
Register |
| Tue 08/24/10 6:00 PM ET |
Topic: Nutrition |
Hilton Suites Lexington Green Hotel 245 Lexington Green Circle Lexington, KY |
Register |
| Thu 08/26/10 6:00 PM ET |
Topic: Nutrition |
Gilda's Club Western New York 1140 Delaware Avenue Buffalo, NY |
Register |
| Tue 08/31/10 6:00 PM ET |
Topic: Nutrition |
Best Western Country Cupboard Inn 101 Hafer Road Lewisburg, PA |
Register |
| Thu 09/09/10 6:00 PM PT |
Topic: Nutrition |
Piccadilly Inn University 4961 N. Cedar Fresno, CA |
Register |
| Sat 09/11/10 9:30 AM PT |
Topic: Nutrition |
Doubletree Hotel Sacramento 2001 Point West Way Sacramento, CA |
Register |
| Tue 09/21/10 6:00 PM ET |
Topic: Sexuality |
Morrison Auditorium University of Tennessee Medical Center, 1924 Alcoa Hwy Knoxville, TN |
Register |
| Tue 09/21/10 6:00 PM CT |
Topic: Nutrition |
Victory in the Valley 3755 East Douglas Avenue Wichita, KS |
Register |
| Thu 09/23/10 6:00 PM CT |
Topic: Nutrition |
Le Pavillon Hotel 833 Poydras Street New Orleans, LA |
Register |
| Tue 09/28/10 6:15 PM CT |
Topic: Nutrition |
City Club 301 Commerce Street Fort Worth, TX |
Register |
| Wed 09/29/10 6:00 PM ET |
Topic: Nutrition |
The Wellness Community of Southeast Michigan 2010 Hogback Road Suite 3 Ann Arbor, MI |
Register |
| Thu 09/30/10 6:00 PM ET |
Topic: Sexuality |
Spectacular Event Center 395 Griffin Road Bangor, ME |
Register |
| Thu 09/30/10 6:00 PM CT |
Topic: Nutrition |
Omaha Marriott Hotel 10220 Regency Circle Omaha, NE |
Register |
| Sat 10/02/10 9:30 AM PT |
Topic: Sexuality |
Vintners Inn 4300 Barnes Road Santa Rosa, CA |
Register |
| Tue 10/05/10 6:00 PM MT |
Topic: Nutrition |
Antlers Hilton Colorado Springs 4 S Cascade Avenue Colorado Springs, CO |
Register |
| Thu 10/07/10 6:00 PM ET |
Topic: Sexuality |
Gilda's Club Rochester New York 255 Alexander Street Rochester, NY |
Register |
| Sat 10/09/10 9:30 AM ET |
Topic: Nutrition |
The Gathering Place East 23300 Commerce Park Beachwood, OH |
Register |
| Thu 10/14/10 6:00 PM ET |
Topic: Nutrition |
The Forum Civic Center 2 Government Plaza Rome, GA |
Register |
| Fri 10/15/10 5:00 PM ET |
Topic: Nutrition |
Sheraton Hotel and Towers 811 Seventh Avenue at 53rd Street New York, NY |
Register |
| Thu 10/21/10 6:00 PM PT |
Topic: Sexuality |
Gilda's Club Seattle 1400 Broadway Seattle, WA |
Register |
| Fri 10/22/10 5:00 PM ET |
Topic: Nutrition |
Charlotte Convention Center 501 South College Street Charlotte, NC |
Register |
| Thu 11/04/10 6:00 PM CT |
Topic: Nutrition |
Waterford Marriott 6300 Waterford Boulevard Oklahoma City, OK |
Register |
| Thu 11/11/10 6:00 PM ET |
Topic: Nutrition |
Hilton Greenville 45 West Orchard Park Drive Greenville, SC |
Register |
| Tue 11/16/10 6:00 PM CT |
Topic: Nutrition |
Crowne Plaza Minneapolis North 2200 Freeway Blvd. Brooklyn Center, MN |
Register |
|
Topic: Sexuality |
Breast Cancer, Sexuality and You Video A HERStory Web Event |
Register | |
| Can’t find an event near you? Sign up for an online event, or watch past events. | |||
Who is Herceptin for?
Herceptin is approved for the adjuvant treatment of HER2-overexpressing, node-positive or node-negative (ER/PR-negative or with one high-risk feature)† breast cancer. Herceptin can be used several different ways:
- As part of a treatment regimen including doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel
- With docetaxel and carboplatin
- As a single agent following multi-modality anthracycline-based therapy
Herceptin in combination with paclitaxel is approved for the first-line treatment of HER2-overexpressing metastatic breast cancer. Herceptin as a single agent is approved for treatment of HER2-overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease.
† High-risk is defined as ER/PR positive with one of the following features: tumor size >2 cm, age <35 years, or tumor grade 2 or 3.
What important safety information should I know about Herceptin?
Herceptin treatment can result in heart problems, including those without symptoms (reduced heart function) and those with symptoms (congestive heart failure). The risk and seriousness of these heart problems were highest in people who received both Herceptin and a certain type of chemotherapy (anthracycline). Your doctor will stop or strongly consider stopping Herceptin if you have a significant drop in your heart function.
You should be monitored for decreased heart function before your first dose of Herceptin, and frequently during the time you are receiving Herceptin and after your last dose of Herceptin. If you must permanently or temporarily stop Herceptin due to heart problems, you should be monitored more frequently. In one study with Herceptin and certain types of chemotherapy, an inadequate blood supply to the heart occurred.
Some patients have had serious infusion reactions and lung problems; fatal infusion reactions have been reported. In most cases, these reactions occurred during or within 24 hours of receiving Herceptin. Your Herceptin infusion should be temporarily stopped if you have shortness of breath or very low blood pressure. Your doctor will monitor you until these symptoms go away. If you have a severe allergic reaction, swelling, lung problems, inflammation of the lung, or severe shortness of breath, your doctor may need to completely stop your Herceptin treatment.
Worsening of low white blood cell counts associated with chemotherapy has also occurred.
Herceptin can cause low amniotic fluid levels and harm to the fetus when taken by a pregnant woman.
The most common side effects associated with Herceptin were fever, nausea, vomiting, infusion reactions, diarrhea, infections, increased cough, headache, fatigue, shortness of breath, rash, low white and red blood cells, and muscle pain.
Because everyone is different, it is not possible to predict what side effects any one person will have. If you have questions or concerns about side effects, talk to your doctor.
Please see the Herceptin full Prescribing Information including Boxed WARNINGS and additional important safety information.
Herceptin® (trastuzumab)
- Home
- HER2 and Breast Cancer Education
- Adjuvant Treatment
- Metastatic Treatment
- Community
- Resource Center
- What do Adjuvant and Metastatic mean? Learn more.
Adjuvant Care Is defined as additional treatment given after the main treatment plan to decrease the chance of recurrence. Adjuvant therapy for breast cancer can include chemotherapy, hormone therapy, radiation therapy, or biological therapy
Metastatic Breast Cancer Breast cancer that has spread to other sites in the body; also referred to as invasive or infiltrating
